Abstract
Chronic renal failure is associated with various haemostatic defects.Patients with chronic renal failure have increased bleeding tendency. The laboratory parameter which appears to correlate the best with the risk of haemorrhage is the bleeding time. Current therapy to correct uraemic bleeding includes dialysis intensification,blood and cryoprecipitate transfusions, estrogens or 1-deamino-8 -D -arginine vasopressin (DDAVP, desmopressin). DDAVP is a synthetic vasopressin analogue devoid of vasoconstrictory action which shortens the bleeding time in patients with mild haemophilia [l],von Willebrand disease [1] or platelet function defects [2,3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mannucci PM. Ruggeri ZM. Pareti FJ. Capitanio A (1977) Lancet 1: 869–872
Kobrinsky NL. Israels ED. Gerrard JM. Cheang MS. Watson CM. Bishop AJ. Schroeder ML (1984) Lancet 1: 1145–1148
Schulman S. Johnsson H. Edberg N. Blomback N (1987) Thromb Res 45: 165–174
Watson AJS. Koegh JAB (1982) Nephron 4:260–261
Mannucci PM. Remuzzi G. Pusineri F. Lombardi R. Valsecchi C. Mecca G. Zimmerman TS (1983) N Engl J Med 308: 8–12
Rydzewski A. Rowinski M. Mysliwiec M (1986) Folia Haematol (Leipzig) 113: 823–830
Malyszko J. Pietraszek M. Buczko W. Mysliwiec M (1990) Folia Haematol (Leipzig) 117: 319–324
Ruggeri ZM. Mannucci PM. Lombardi R. Federici AB. Zimmerman TS (1981) Blood 59: 1272–12
Grant MB. Guay C. Lottenberg R (1988) Thromb Haemostas 59: 269–272
DeClerk T. Somers Y. van Gorp L (1984) Agents Action 15: 627–635
Mielke CH. Kaneshiro JA. Maher JA. Wessler JM. Rapaport SI (1969) Blood 34: 204–215
Laurell CB (1966) Anal Biochem 15: 45–52
Bukh A. Ingerslev J. Stenbjerg S. Hundahl-Moller NP (1986) Thromb Res 43: 579–585
Achroft G. Crawford TB (1964) Clin Chim Acta 9: 364–369
Drummond AH. Gordon JL (1974) Thromb Diathes haemorrh (Stuttgart) 31: 366
Lingjaerde D (1979) Acta Pharmacol Toxicol 45: 394
Gordon JL. Olverman HJ (1978) Brit J Pharmacol 62: 219
Kowarzyk H. Buluk K (1950) Post Hig Med Dosw 2: 1–76
Chmielewska JN. Wiman B (1985) Clin Chem 32: 482–485
DiMichele DM. Hatheway WME (1990) Am J Haematol 33: 39–45
Moffat EH. Giddings JC. Bloom AL (1984) Brit J Haematol 57: 651–652
Mannucci PM. Canciani MZ. Roto L. Donovani BS (1979) Brit J Haematol 43: 283–293
Brommer EJP. Derkx FHM. Barret-Bergshoeff MM. Schalekamp MADH (1984) Thromb Haemostas 51: 42–44
D’Angelo A. Capitanio A. Smith JB. Vasecchi C. Mannucci PM (1983) Thromb Haemostas 49: 64
Malyszko J. Pietraszek M. Azzadin A. Buczko W. Mysliwiec M (1990) Thromb Haemostas 61: 637
Yang X. Disa J. Rao AK (1990) Thromb Res 59: 809–810
Soslau G. Schwartz AB. Putatunda B. Conroy JD. Parker J. Abel RF. Brodsky I (1990) Am J Med Sciences 299; 372–379
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Japan
About this paper
Cite this paper
Mysliwiec, M., Malyszko, J.S., Malyszko, J., Pietraszek, M., Azzadin, A., Buczko, W. (1992). Haemostatic Studies in Uraemic Patients Following DDAVP Administration. In: Takada, A., Budzynski, A.Z. (eds) Hemostasis and Circulation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66925-8_27
Download citation
DOI: https://doi.org/10.1007/978-4-431-66925-8_27
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70096-8
Online ISBN: 978-4-431-66925-8
eBook Packages: Springer Book Archive